Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
27 participants
OBSERVATIONAL
2022-10-06
2024-05-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Precision Nutrition and Metabolic Function
NCT04131166
Evaluation of a Nutritional Intervention With Dietary Supplements in People Who Have Recently Lost Weight: Effects on Body Composition, Emotional Health, and Gut Microbiota
NCT07269821
Effects of Dietary Manipulation on Metabolism in Healthy Adults
NCT00476125
Valued EpiGenetic Glycemic ImprovEments Through Weight Loss
NCT02869659
Diabetes Nutrition Algorithms in Patients With Overt Diabetes Mellitus
NCT02459496
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
Intensive lifestyle change therapy
Participant of both groups will be followed for 24 months after completing the parent trial intervention, with no intervention during the follow-up
Tirzepatide
Tirzepatide
Participant of both groups will be followed for 24 months after completing the parent trial intervention, with no intervention during the follow-up
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intensive lifestyle change therapy
Participant of both groups will be followed for 24 months after completing the parent trial intervention, with no intervention during the follow-up
Tirzepatide
Participant of both groups will be followed for 24 months after completing the parent trial intervention, with no intervention during the follow-up
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pennington Biomedical Research Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eric Ravussin
Associate Executive Director for Clinical Science
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pennington Biomedical Research Center
Baton Rouge, Louisiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PBRC 2022-027
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.